Trinity Biotech (TRIB) has entered into a $25M Standby Equity Purchase Agreement with an affiliate of financing partner Yorkville Advisors Global. The agreement provides Trinity Biotech with an additional funding tool designed to augment the Company’s commercialisation initiatives and to support its high-potential R&D programs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Warned by Nasdaq Over Minimum Public Float Value
- Trinity Biotech receives noncompliance notification from Nasdaq
- Trinity Biotech Faces Nasdaq Bid-Price Deficiency, Given Until August to Regain Compliance
- Trinity Biotech’s Premier Hb9210 Wins Sole IFCC Gold HbA1c Classification for 2026
- Trinity secures regulatory approval for upstream manufacturing activities